| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,505 | 0,585 | 10.02. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.01. | ADVANCE ZINCTEK LIMITED: FDA Update | 1 | ASX | ||
| 12.12.25 | ADVANCE ZINCTEK LIMITED: Response to Television Broadcast Early This Week | - | ASX | ||
| 09.12.25 | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | 1 | ASX | ||
| 08.12.25 | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | - | ASX | ||
| 05.12.25 | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | - | ASX | ||
| 28.11.25 | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | - | ASX | ||
| ADVANCE ZINCTEK Aktie jetzt für 0€ handeln | |||||
| 17.11.25 | ADVANCE ZINCTEK LIMITED: FDA Inspection Update | - | ASX | ||
| 14.11.25 | ADVANCE ZINCTEK LIMITED: Results of Meeting | 1 | ASX | ||
| 13.11.25 | ADVANCE ZINCTEK LIMITED: Chair's Presentation to Shareholders | - | ASX | ||
| 17.10.25 | ADVANCE ZINCTEK LIMITED: Notice of Annual General Meeting/Proxy Form | 1 | ASX | ||
| 02.10.25 | ADVANCE ZINCTEK LIMITED: Improvement of 26.83% in First Quarter Revenue - FY26 | 2 | ASX | ||
| 26.09.25 | ADVANCE ZINCTEK LIMITED: Statement Regarding US Pharmaceutical Tariffs | - | ASX | ||
| 03.09.25 | ADVANCE ZINCTEK LIMITED: Response to Rumours Re CHOICE Sunscreen Test Findings | 1 | ASX | ||
| 29.08.25 | ADVANCE ZINCTEK LIMITED: Corporate Governance Statement | 2 | ASX | ||
| 29.08.25 | ADVANCE ZINCTEK LIMITED: Appendix 4G | 1 | ASX | ||
| 29.08.25 | ADVANCE ZINCTEK LIMITED: Annual Report to shareholders | 1 | ASX | ||
| 29.08.25 | ADVANCE ZINCTEK LIMITED: Appendix 4E | 1 | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 23,500 | +1,08 % | EQS-DD: Formycon AG: Active Ownership Fund SICAV SIF SCS, Verkauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
14.01.2026 / 19:31... ► Artikel lesen | |
| ONTO INNOVATION | 184,00 | +2,22 % | Beyond The Numbers: 8 Analysts Discuss Onto Innovation Stock | ||
| RIBER | 5,280 | +0,96 % | Riber's full-year 2025 revenue falls by 2% to €40.3m, but second-half up 7% year-on-year | ||
| DOTZ NANO | 0,025 | +4,26 % | DOTZ NANO LIMITED: Becoming a substantial holder | ||
| KOPIN | 1,951 | -1,71 % | Kopin-Aktie legt zu: Rüstungsauftrag für Pilotenhelm-Displays erhalten | ||
| GAUZY | 0,791 | 0,00 % | Gauzy Ltd. Announces Receipt of Nasdaq Notice Regarding Board Composition Requirements | TEL AVIV, Israel, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (NASDAQ: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced that it has received... ► Artikel lesen | |
| CANATU | 10,200 | 0,00 % | Canatu Oyj: Canatu and DENSO enter Joint Development Agreement to develop large-scale CNT chamber, supporting potential automotive applications such as full windshield heaters | Canatu Plc Press release 2 January 2026 at 09:00 am EET
Canatu and DENSO enter Joint Development Agreement to develop large-scale CNT chamber, supporting potential automotive applications such as full... ► Artikel lesen | |
| REGION GROUP | 1,435 | +8,47 % | Region Group 1H FY26 presentation: FFO growth and upgraded guidance on strong retail performance | ||
| NANOLOGICA | 0,059 | 0,00 % | Flerie AB: Flerie's portfolio company Nanologica acquires Syntagon | Flerie AB (publ)'s portfolio company Nanologica has acquired Ardena Södertälje AB ('Syntagon'), a contract manufacturer with 45 employees. The acquisition strengthens Nanologica's production capacity... ► Artikel lesen | |
| GOMSPACE | 2,130 | +1,67 % | GomSpace Group AB: GomSpace announces 2026 market guidance with strong profitable growth | GomSpace, a leading provider of small satellite solutions, today provides an update on its 2026 financial guidance.
The company is pleased to announce comprehensive market guidance for 2026, reflecting... ► Artikel lesen | |
| VEECO INSTRUMENTS | 25,000 | -2,34 % | Axcelis Technologies, Inc.: Axcelis Stockholders Approve Merger with Veeco | BEVERLY, Mass., Feb. 6, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) ("Axcelis") today announced that its stockholders have voted to approve all... ► Artikel lesen | |
| SOLESENCE | 1,460 | +4,29 % | Solésence, Inc.: Solésence Reports Third Quarter 2025 Financial Results | Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN)... ► Artikel lesen | |
| ZENTEK | 0,555 | -3,48 % | Zentek Ltd.: Zentek Issues Shareholder Letter Outlining Strategic Reset and Focused Growth Plan | Guelph, Ontario--(Newsfile Corp. - January 29, 2026) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company") today announced that it has issued a letter to shareholders outlining a... ► Artikel lesen | |
| NANOVIRICIDES | 0,795 | -1,24 % | Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides | SHELTON, CONNECTICUT / ACCESS Newswire / February 10, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the... ► Artikel lesen | |
| OBDUCAT | 0,002 | -33,33 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 31.12.2025 | Das Instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY wird cum Kapitalmassnahme gehandelt am 31.12.2025 und ex Kapitalmassnahme am 02.01.2026 The instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY... ► Artikel lesen |